INVENTRONICS LTD (IVX.CA) Stock Fundamental Analysis
TSX-V:IVX - TSX Venture Exchange - CA4612082095 - Common Stock - Currency: CAD
Taking everything into account, IVX scores 3 out of 10 in our fundamental rating. IVX was compared to 2 industry peers in the Building Products industry. IVX has an average financial health and profitability rating. IVX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
IVX had positive earnings in the past year.
IVX had a positive operating cash flow in the past year.
Of the past 5 years IVX 4 years were profitable.
In the past 5 years IVX always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 1.84%, IVX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
With a Return On Equity value of 4.61%, IVX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
IVX's Return On Invested Capital of 3.94% is on the low side compared to the rest of the industry. IVX is outperformed by 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IVX is significantly above the industry average of 5.22%.
The last Return On Invested Capital (3.94%) for IVX is well below the 3 year average (16.93%), which needs to be investigated, but indicates that IVX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 4.61% | ||
| ROIC | 3.94% |
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
1.3 Margins
IVX's Profit Margin of 1.55% is on the low side compared to the rest of the industry. IVX is outperformed by 66.67% of its industry peers.
Looking at the Operating Margin, with a value of 3.92%, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of IVX has declined.
The Gross Margin of IVX (17.94%) is worse than 66.67% of its industry peers.
IVX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.92% | ||
| PM (TTM) | 1.55% | ||
| GM | 17.94% |
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IVX is creating value.
IVX has about the same amout of shares outstanding than it did 1 year ago.
IVX has more shares outstanding than it did 5 years ago.
IVX has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.37 indicates that IVX is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.37, IVX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Debt to FCF ratio of IVX is 4.28, which is a neutral value as it means it would take IVX, 4.28 years of fcf income to pay off all of its debts.
IVX has a worse Debt to FCF ratio (4.28) than 66.67% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that IVX is somewhat dependend on debt financing.
IVX's Debt to Equity ratio of 0.90 is on the low side compared to the rest of the industry. IVX is outperformed by 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | 2.37 |
ROIC/WACC0.46
WACC8.55%
2.3 Liquidity
IVX has a Current Ratio of 2.34. This indicates that IVX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.34, IVX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 1.54 indicates that IVX should not have too much problems paying its short term obligations.
IVX has a better Quick ratio (1.54) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.34 | ||
| Quick Ratio | 1.54 |
3. Growth
3.1 Past
IVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 113.76%, which is quite impressive.
Looking at the last year, IVX shows a small growth in Revenue. The Revenue has grown by 4.99% in the last year.
The Revenue has been growing slightly by 2.21% on average over the past years.
EPS 1Y (TTM)113.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2250%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%69.48%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 34.50, IVX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of IVX indicates a somewhat cheap valuation: IVX is cheaper than 66.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, IVX is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVX indicates a somewhat cheap valuation: IVX is cheaper than 66.67% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVX indicates a rather cheap valuation: IVX is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.01 | ||
| EV/EBITDA | 10.8 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for IVX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:IVX (7/10/2025, 7:00:00 PM)
0.69
-0.06 (-8%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap3.36M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP430.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.5 | ||
| Fwd PE | N/A | ||
| P/S | 0.46 | ||
| P/FCF | 6.01 | ||
| P/OCF | 4.59 | ||
| P/B | 1.37 | ||
| P/tB | 1.37 | ||
| EV/EBITDA | 10.8 |
EPS(TTM)0.02
EY2.9%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY16.64%
OCF(TTM)0.15
OCFY21.78%
SpS1.5
BVpS0.5
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 4.61% | ||
| ROCE | 5.84% | ||
| ROIC | 3.94% | ||
| ROICexc | 4.34% | ||
| ROICexgc | 4.34% | ||
| OM | 3.92% | ||
| PM (TTM) | 1.55% | ||
| GM | 17.94% | ||
| FCFM | 7.65% |
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
ROICexc(3y)18.71%
ROICexc(5y)18%
ROICexgc(3y)18.71%
ROICexgc(5y)18%
ROCE(3y)25.1%
ROCE(5y)24.63%
ROICexcg growth 3Y-68.88%
ROICexcg growth 5Y-39.12%
ROICexc growth 3Y-68.88%
ROICexc growth 5Y-39.12%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
F-Score7
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 4.53 | ||
| Cap/Depr | 86.5% | ||
| Cap/Sales | 2.37% | ||
| Interest Coverage | 1.99 | ||
| Cash Conversion | 150.62% | ||
| Profit Quality | 494.69% | ||
| Current Ratio | 2.34 | ||
| Quick Ratio | 1.54 | ||
| Altman-Z | 2.37 |
F-Score7
WACC8.55%
ROIC/WACC0.46
Cap/Depr(3y)281.39%
Cap/Depr(5y)239.45%
Cap/Sales(3y)5.39%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)113.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2250%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%69.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.55%
EBIT growth 3Y-69.33%
EBIT growth 5Y-34.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.84%
FCF growth 3Y-16.33%
FCF growth 5Y11.05%
OCF growth 1Y-74.33%
OCF growth 3Y-11.65%
OCF growth 5Y14.04%